Symbols

AbbVie Stock Drops 3.14% on April 10 2025 with $23.77 Billion Trading Volume Ranking 34th in Market Activity

Generated by AI AgentAinvest Market Brief

Thursday, Apr 10, 2025 8:00 pm ET1min read

AbbVie (ABBV) shares fell 3.14% on April 10, 2025, with a trading volume of $23.77 billion, ranking 34th in the day's market activity.

Wells Fargo analyst Mohit Bansal maintained a Buy rating on AbbVieABBV--, setting a price target of $240.00. This rating reflects the firm's confidence in the company's future performance and growth prospects.

Morgan Stanley has also raised its price target for AbbVie to $241 from $239, indicating a positive outlook on the company's stock. This adjustment suggests that analysts are optimistic about AbbVie's potential for growth and profitability.

Ainvest Market Brief

Market Watch column provides a thorough analysis of stock market fluctuations and expert ratings.

Latest Articles

Stay ahead of the market.

Get curated U.S. market news, insights and key dates delivered to your inbox.

Comments

﻿

Add a public comment...

No comments yet

AInvest
PRO

Editorial Disclosure & AI Transparency: Ainvest News utilizes advanced Large Language Model (LLM) technology to synthesize and analyze real-time market data. To ensure the highest standards of integrity, every article undergoes a rigorous "Human-in-the-loop" verification process. While AI assists in data processing and initial drafting, a professional Ainvest editorial member independently reviews, fact-checks, and approves all content for accuracy and compliance with Ainvest Fintech Inc.’s editorial standards. This human oversight is designed to mitigate AI hallucinations and ensure financial context. Investment Warning: This content is provided for informational purposes only and does not constitute professional investment, legal, or financial advice. Markets involve inherent risks. Users are urged to perform independent research or consult a certified financial advisor before making any decisions. Ainvest Fintech Inc. disclaims all liability for actions taken based on this information. Found an error?Report an Issue